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Several autoantibodies have been  described in autoimmune thyroid diseases 
with specificities for antigens localized to the ("microsomal") acinar cell cytoplasm, 
colloid  space  (thyroglobulin, second  colloid antigen),  and  surface  membrane 
(TSH-receptor and other as yet unidentified moieties) (1). 
If circulating antibodies play any direct role  in  the  pathogenesis of human 
thyroid disease, for example by mediating cytolysis, or by blocking or stimulating 
function and growth (2), they must be able to interact in vivo with their specific 
antigens.  This  interaction will  depend  upon  the accessibility of autoantigenic 
determinants on  the cell surface, on basal  membranes, and in the circulation, 
and the availability of adequate amounts of antibody in intravascular and inter- 
stitial fluids. 
Immunohistological examination of the affected target tissue, by direct im- 
munofluorescence (IFL)  l with labeled anti-immunoglobulin (Ig) or anti-comple- 
ment sera, is an accepted way of looking for evidence of in vivo autoreactivity. 
Glands from patients with autoimmune thyroid disease have  been  repeatedly 
screened by this procedure and granular deposits of Ig often associated with 
complement, were described in the colloid, in the connective-tissue stroma and 
along the follicular basement membrane (FBM; references 3-6). Thyroglobulin 
is the most likely target for colloid-bound Ig and is also believed to be involved 
in some instances in immune complexes deposited around the FBM (7). On the 
other hand,  no direct evidence was  found under these conditions concerning 
binding  in  vivo  of autoreactive  Ig  on  the  follicular  epithelium,  though  the 
presence of Ig deposits on isolated cells  from thyrotoxic glands has been men- 
tioned (8). 
Recently, it has been established that the cytoplasmic microsomal autoantigen 
is also present on the cell surface of human thyroid cells maintained in monolayer 
cultures (9).  The same cell surface autoantigen is involved in the complement- 
Supported by funds from the British Medical Research Council. E. L. K. was a Wellcome  Trust 
Research Fellow. 
* Correspondence should be addressed to Dr. G. F. bottazzo  at the Dept. of Immunology,  The 
Middlesex Hospital Medical  School, Arthur Stanley  House, 40-50 Tottenham  Street, London  WI P 
9PG. E. L. Khoury's  present address is: Div. of Oral Biology,  HSW-604, University  of California  at 
San Francisco,  San Francisco, CA 94143. 
1  Abbreviations used in this paper: C3, third component  of complement;  CM, culture medium; FBM, 
follicular basement membrane, FCS, fetal calf  serum; IFL, immunofluorescence;  PBS, phosphate- 
buffered  saline; TMAb, thyroid  microsomal  antibodies. 
J. ExP. MED. © The Rockefeller  University  Press • 0022-1007/84]02/0577/15 $1.00  577 
Volume 159  February  1984  577-591 578  THE  THYROID  "MICROSOMAL" ANTIBODY REVISITED 
mediated  antibody-dependent  cytotoxic  effect exerted  in  vitro  by  sera  from 
autoimmune thyroid disease patients, positive for thyroid microsomal antibodies 
(TMAb).  On the other hand, no direct evidence has been found ~oncerning in 
vivo autoreactivity of TMAb,  even  though their presence  in  the circulation is 
almost invariably associated with autoimmune thyroid disease. 
In the course of IFL studies on the cell-surface reactivity of TMAb on human 
thyroid cultures (9)  it became apparent that, while follicular cells from normal 
glands were always negative when tested by direct IFL with anti-Ig conjugates, 
those obtained from the thyroids of patients with circulating TMAb frequently 
displayed  spontaneous  surface-bound  Ig.  These  observations  prompted  us  to 
look systematically for the binding in  vivo of these antibodies to thyroid cells. 
Evidence  is  also  presented  which  indicates  that  the  surface expression  of the 
microsomal autoantigens on the thyroid cell epithelium is restricted  in vivo to 
the apical border of the follicular cells and therefore may not be readily accessible 
to circulating antibodies. 
Materials and Methods 
Direct hnmunofluorescent Staining on Frozen Thyroid Sections 
17 glands were used for these experiments. Operative specimens were obtained from 
13  patients with thyrotoxicosis, 3 with diffuse or nodular nontoxic goiter, and  1 with 
dyshormonogenetic goiter. In each case and in all subsequent experiments, the diagnosis 
was  confirmed on  clinical,  laboratory, and  histological grounds.  Staining for in  vivo 
immunoglobulin deposits was carried out according to established techniques (3, 5, 7). In 
brief, 4-#m freshly cut cryostat thyroid sections were washed in phosphate-buffered saline 
(PBS) for  15  rain and subsequently incubated with fluorescein-conjugated anti-human 
Fab, IgG, IgM, and third component of complement (C3) for 30 rnin at room temperature. 
All antisera were diluted 1:20 before use. Sections were washed again in PBS for 15 min 
and  mounted.  These  and  all  subsequent  preparations  described  in  this  paper  were 
examined under a Zeiss fluorescence microscope equipped with epiillumination and phase 
contrast. 
hnmunofluorescent Staining of Thyroid Monolayers 
Substrates.  41  human thyroids were used. Tissues were obtained from the following 
patients: 10 with Graves' thyrotoxicosis, 2 with Hashimoto's thyroiditis, 6 with diffuse or 
nodular nontoxic goiter,  1 with dyshormonogenetic goiter, and 8  with adenomatous, 
carcinomatous, or cystic lesions  where normal peri-lesional  tissue  was used.  12 normal 
adult thyroids, obtained from patients undergoing radical neck surgery for cancer of the 
larynx, and 2 from 14- and 17-wk-old fetuses were used as controls. Serum samples from 
1 patient with thyrotoxicosis, 2 with thyroid cysts, and 1 with adenoma, and from the 12 
donors of normal thyroid tissue were not available for the conventional hemagglutination 
tests for thyroglobulin and thyroid microsomal autoantibodies (Wellcome Reagents). 
Preparation of Thyroid Monolayer Cultures.  The procedure followed for obtaining viable 
cells and establishing the cultures was recently described (9). In brief, the glands were 
obtained immediately after removal and processed under sterile conditions. The thyroid 
tissue was chopped into small pieces, washed several times in culture medium (CM) (Flow 
199 plus NaHCO 0.35 mg/ml, penicillin 300 U/ml, and streptomycin 300 ug/ml) and 
incubated for 60 to 90 rain at 37°C with either collagenase (Worthington type IV, 2 mg/ 
ml), trypsin, (Difco, 2.5 mg/ml) or collagenase followed by trypsin (60 rain each).  After 
discarding undigested  tissue  fragments and  iysing erythrocytes in  0.83%  ammonium 
chloride buffer, the thyroid cells were washed and resuspended in CM supplemented with 
15% heat-inactivated fetal calf serum (FCS). Cell viability after dispersion was assessed by 
differential staining with an acridine orange/ethidium bromide mixture under fluores- KHOURY  ET  AL.  579 
cence microscopy (10) and was >90%  in all preparations. An accurate cell count at this 
stage  was  not  feasible, as  most  thyroid  cells  were  in  clusters  (11).  100  tA  of the  cell 
suspension were plated on to round coverslips,  13 mm in diameter, placed in multiwell 
(Linbro) plates and 400/zl of 15% FCS in CM added to each well. The cultures were kept 
at 37°C in a 5% CO2 humidified cell incubator until tested by IFL. 
Staining Procedure.  18-36-h-old  viable  monolayers were  employed in  these  experi- 
ments. For the direct method the monolayers were washed in CM and then incubated for 
30 rain at room temperature with a fluorescein-conjugated sheep anti-human Fab serum 
diluted  1:20 in CM.  In addition,  monolayers from 12 of the abnormal glands were also 
stained with monospecific fluorescein-conjugated sheep antisera against human IgG, IgM, 
IgA, and C3 (Wellcome Reagents), diluted  1:20  under the same conditions.  In some of 
the cases in which negative IFL was obtained, staining was repeated with lower dilutions 
of these conjugates.  In 9  cases, both monolayer cultures and frozen sections from the 
same gland were stained. 
For the indirect method, the viable cell-monolayers were first incubated with known 
TMAb-positive sera giving organ-specific thyroid cell-surface IFL staining (9)  and the 
reaction  subsequently  revealed  with  the  anti-Fab  conjugate.  Cultures  from  20  of the 
abnormal glands were additionally tested with the autologous serum. Control sera were 
from healthy laboratory staff, negative for thyroid or other autoantibodies and with no 
family history of organ-specific autoimmune disease. 
Complement Fixation and Cytotoxicity In Vitro 
To detect complement fixation in  vitro,  the monolayers were incubated with  blood 
group AB (12),  fresh normal human  serum  (FNHS) diluted  1:5  in  CM as a  source of 
complement, and counterstained  with  anti-C3  conjugate.  In addition,  cell  suspensions 
from all 41  thyroid glands were incubated with 20% blood group AB, FNHS in CM for 
48 h at 37°C in the cell incubator, in order to detect any direct cytotoxic effect of the 
added complement by screening the preparations under phase contrast in an inverted 
microscope (9). 
Immunofluorescent Staining of Partially Disrupted  Thyroid Follicles in Suspension 
Substrates.  Six human thyroids were used for this study. Three were thyrotoxic glands, 
two were nontoxic goiters and one was a  normal thyroid.  To obtain partially digested 
follicles, the  thyroid  tissue was chopped into small pieces, washed in  the same culture 
medium, and incubated at 37°C with collagenase (2 mg/ml) for 20-30 min, with gentle 
shaking. After discarding large undigested fragments and lysing the erythrocytes, broken 
follicles, smaller fragments of epithelium, and dispersed thyroid cells were resuspended 
in CM. Cell viability was always >90%. 
Sera.  Several sera positive for TMAb and thyroid cell-surface IFL staining on cultured 
monolayers were used. In addition, the autologous serum was tested on all but the normal 
thyroid. 
Staining Procedure.  Immediately after the enzymatic digestion  180 #1 aliquots of the 
cell suspension and 20 #1 of undiluted test serum were placed in 4-ml centrifuge tubes, 
making a final serum dilution of 1:10.  The mixture was incubated in an ice bath for 30 
min with frequent gentle shaking. The tubes were then filled with culture medium and 
centrifuged at 150 g for 5 min. The cell pellet was resuspended in 100 #1 of a fluorescein 
sheep anti-human Fab conjugate diluted  1:50, and incubated for a further 30 rain. After 
a  second  wash and  centrifugation,  the  cell pellet was resuspended  in  50  #1  of culture 
medium  and  a  drop  of the  suspension  placed  on  a  microscope slide,  mounted,  and 
examined under fluorescence microscopy. In the direct IFL staining the test serum was 
omitted and the same anti-human Fab conjugate was used to reveal spontaneous binding 
of Ig in vivo. An anti-C3 conjugate was also used. 
Results 
Immunoglobulin  Deposition on Frozen Thyroid Sections.  When  unfixed  cryostat 
sections  of  randomly  selected  tissue  blocks  from  13  thyrotoxic  glands  were 580  THE  THYROID  "M!CROSOMAL"  ANTIBODY  REVISITED 
stained  by  direct  IFL,  clev  cut  linear  deposits  of  IgG  delineating  the  apical 
border of the follicular  epituclium  were  seen  in  6  cases (Fig.  1;  Table  I).  This 
pattern,  though essentially focal and restricted  to some follicles on each section, 
was quite uniform at the inner edge of a given follicle.  Even when in some cases 
there  were  strong deposits on  the apical  surface,  intracytoplasmic  staining  was 
seen in some thyroid cells in only one of the glands examined.  Neither  IgM nor 
C3 could be found in these deposits.  Likewise,  no complement-fixation  in vitro 
could be  detected  in  these  glands  when  sections  positive  for bound  IgG  were 
FIGURE  |.  Frozen tissue section from a thyrotoxic  gland stained by direct immunofluores- 
cence with conjugated anti-human IgG showing a continuous linear staining on the apical 
border ofacinar cells, x 250. 
TABLE  I 
In Vivo Deposition of lmmunoglobulins  and Complement in Operative Specimens of Thyroid 
Glands 
Thyroid donors  Thyroid preparations 
Direct immunofluorescence 
AntMgG  Anti-IgM  Anti-C3 
no. positive~no, tested 
Graves' thyrotoxicosis  Unfixed cryostat sections: 
Apical border  "6/13  0/10  0/10 
Follicular basement membrane  "5/13  4/10  5/10 
Monolayer cultures  '8/10  0/6  /6 
Hashimoto's goiter  Monolayer cultures  2/2  0/2  0/2 
Other thyroid lesions  Unfixed cryostat sections: 
Apical border  01/4  0/4  0/4 
Follicular basement membrane  0/4  0/4  0/4 
Monolayer cultures  02/15  0/4  0/4 
Normals  Monolayer cultures  0/14  NT  NT 
NT, not tested. 
* Only one gland showed simultaneous apical border and basement membrane staining. Altogether 
10/13 thyrotoxic glands showed some in vivo fixation of antibodies on sections. 
* 5/8 positive monolayers were derived from glands showing deposits of microvillar antibodies on 
sections. 
§ The three glands showing microvillar deposits on sections or monolayer culture were from patients 
with nontoxic diffuse or nodular goiters and circulating thyroid microsomal antibodies. KHOURY  ET  AL.  581 
incubated  with  FNHS  and  counterstained  with  fluoresceinated anti-C3.  IgA 
deposition was not looked for. 
The staining on the apical border was always correlated with positive thyroid 
microsomal antibodies in the patient's serum, but glands from three thyrotoxic 
TMAb-positive patients did not show this in vivo Ig deposition. Thyroid sections 
of three TMAb-negative thyrotoxicosis cases were negative for Ig deposits on 
the  apical  border  and  only one  of the  nontoxic  goiters  was  weakly positive 
although in this case the serum had low titer TMAb. The dyshormonogenetic 
goiter was negative. 
In addition, five of the thyrotoxic glands displayed granular deposits of Ig and 
C3 along the follicular basement membrane (Fig.  2).  These deposits varied in 
intensity on different areas, though their presence could always be confirmed on 
sections from several blocks of the same gland. IgG and to a lesser extent IgM 
were found around the FBM. Complement was invariably attached in vivo. No 
correlation  or  topographical  association  was  found  between  apical  and  basal 
immune deposits. Moreover, sections with the strongest deposits along the FBM 
were devoid of staining on the apical pole, and vice versa (Table I). Ig along the 
FMB was not round in the three nontoxic or the dyshormonogenetic goiters. 
Immunoglobulin  Deposition on  Thyroid  Cell Monolayers.  In no instance was cell- 
surface IFL present on cultured thyroid follicular cells from  12  normal adult 
and 2 fetal glands, when directly stained with fluorescein-conjugated anti-human 
Ig (Table I).  Negative results were also obtained on monolayers derived from 
peri-adenomatous or peri-cystic tissue of eight patients,  four nontoxic goiters, 
one dyshormonogenetic goiter, and two thyrotoxic glands, even though some of 
the patients' sera were positive for microsomal antibodies. In  12  other cases (8 
with thyrotoxicosis, 2 with Hashimoto's thyroiditis, and 2 with nontoxic goiter), 
spontaneous cell-surface-bound Ig was detected by direct IFL staining on mon- 
olayers  (Fig.  3a).  The  IFL  pattern  consisted  of coarse  and  sparse  granular 
staining covering the whole surface of the cell (Fig. 3 b), similar to that obtained 
by  indirect  IFL  with  TMAb-positive  sera  on  blood  group  O  normal  thyroid 
FIGURE 2.  Direct immunofluorescence staining of frozen tissue section from a  thyrotoxic 
gland (different from that in Fig.  1) by antMgG conjugate, showing discrete deposits along 
the follicular basement membrane, x  250. 582  THE  THYROID  "MICROSOMAL" ANTIBODY  REVISITED 
FIGURE 3.  Demonstration of in vivo binding of Igs on thyroid follicular cells. After 24 h in 
culture, cells are spread on the coverslip as seen by phase-contrast microscopy (/eft); and when 
stained with anti-Fab conjugate, a significant proportion  (all in this particular field) showed 
granular surface immunofluorescence (right). The large bright areas represent autofluorescent 
intracytoplasmic vacuoles (orange in the original), x 650. 
monolayers  (9).  However,  positive  reactions  for  spontaneously  bound  Ig  were 
usually focal,  involving  fairly  numerous  groups  of follicular  cells,  except  in  the 
cultures  prepared  from  the  Hashimoto  glands,  where  nearly  all  cells displayed 
significant  staining.  This  focal  distribution  allowed  most  cultures  with  sponta- 
neous  deposits  to  be  tested  also  by  indirect  IFL  with  TMAb-positive  sera, 
including  the  patient's  own,  which  produced  a  uniformly  distributed  granular 
staining  on  all  cells.  Spontaneous  membrane-bound  Ig  was  usually  no  longer 
detected after 2  d  in culture,  although  cells were still able to react with TMAb- 
positive sera. 
In an attempt to rule out the possibility that this spontaneous staining reaction 
might  be an  artifact  caused by the binding  of intravascular  or locally produced 
Ig  to  cell-surface  autoantigens  while  the  cells  were  processed  with  proteolytic 
enzymes, two tissue samples from the same portion of a gland were obtained and 
finely minced.  One of the samples  was extensively washed (four to six times)  in 
CM  before  enzymatic  treatment,  while  the  other  was  subjected  to  digestion 
without previous washing.  No qualitative or quantitative  differences in the direct 
staining  with  fluorescein-labeled  anti-Fab  were  recorded  on  cultures  derived 
from  the  samples  processed  in  these  two ways.  This  experiment  was  repeated 
with several glands. 
The correlation  between circulating TMAb and the presence of spontaneously 
cell-surface-bound  Igs on  cultured  monolayers  is shown  in  Fig.  4.  Positive  IFL 
on viable cultures  was never observed when  cells came  from a  TMAb-negative 
donor.  However,  not  all  TMAb-positive  cases showed  spontaneous  Ig deposits 
on the surface of the monolayers,  even though  their sera invariably reacted well 
with  autologous  cultures  in  the  indirect  IFL  test.  Cells  dispersed  from  the 
perilesional  tissue of a follicular adenoma with focal thyroiditis were negative for 
direct  IFL,  even  though  the TMAb  in  the  patient  serum  produced  strong  cell 
surface staining  on autoiogous  24-h old monolayers. 
Fibroblastoid  cells  present  in  the  cultures,  specially  those  of thyrotoxic  and 
Hashimoto  glands,  were invariably  negative  for direct  IFL staining.  Occasional 
spread macrophages  were nonspecifically stained by labeled antisera  due to their 
cell surface Fc receptors. KHOURY  ET  AL.  583 
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FIGURE 4.  Microvillous Ig deposits on thyroid cells in vivo, demonstrated by direct anti-Fab 
staining of viable monolayer cultures, and their correlation with circulating thyroid =microso- 
mal" antibodies, t,  Thyrotoxicosis. A, Hashimoto's thyroiditis. O,  Diffuse or nodular non- 
toxic goiter. A, Single nodule, follicular  adenoma, cyst,  carcinoma,  and  one dyshormonogenetic 
goiter (normal peri-lesional tissue was used in all cases). 
Spontaneous membrane-bound Igs stained for IgG in all cases, but only trace 
amounts of IgA were detected and then in just a small proportion of the cultures. 
IgM and C3 were never found by direct IFL, even when monospecific antisera 
were used at higher concentration. Furthermore, none of the cultures displaying 
cell-surface-bound IgG  in  vivo  fixed  complement spontaneously  in  vitro,  as 
assessed by complement-fixing IFL with FNHS and anti-C3 conjugate on 24-h 
old monolayers or by phase contrast monitoring of cytotoxicity by FNHS alone 
on freshly dispersed cell suspensions. On the other hand, these cultures did show 
significant complement fixation and cytotoxic changes in vitro when incubated 
with autologous serum before the addition of FNHS. 
There was a  noticeable difference in the staining intensity between anti-Fab 
and monospecific anti-IgG labeled antisera, the latter being weaker on cultured 
cells obtained by trypsin digestion. That this was due to an effect of the trypsin 
on the Fc portion  of cell-surface-bound IgG during enzymatic treatment was 
shown by the following experiments. 24-h old monolayers from a normal gland 
were incubated with a TMAb-positive serum as for indirect IFL. The monolayers 
were then detached with 0.25% trypsin solution for 10 min at 37°C, and the cell 
suspension replated on new coverslips after trypsin inactivation with FCS.  24 h 
later the follicular cells had again spread and were directly stained with anti-Fab 
and -IgG conjugates. There was a  significantly brighter staining with anti-Fab 
serum (++  vs.  weak +  with anti-IgG).  Furthermore, these pretreated cultures 
failed to display any complement fixation when incubated successively with FNHS 
and fluorescent anti-C3 conjugate. Nontrypsinized control monolayers showed 
similar staining with anti-Fab and -IgG sera and were positive for complement- 
fixing IFL, when incubated with the same TMAb-positive serum. 
hnmu~wglobulin Deposition and Localizatio~ on Partially  Disrupted Follicles.  Un- 
der phase  contrast microscopy, partially broken  thyroid follicles from the six 
glands used in these experiments often appeared as three-dimensional structures 
resembling  "half-melons"  in  which  a  central  concavity--the  empty  colloid 
space--and a  normally polarized row of follicular cells at the rupture surface, 
were recognized on focusing (Figs.  5 a, and 6,a and c). There were also compact 584  THE THYROID "MICROSOMAL" ANTIBODY REVISITED 
FIGURE 5.  Partially disrupted follicle from a thyrotoxic gland. (Top) Phase-contrast  showing 
the  three-dimensional  structure  ("half-melon"); focus  is on  the  row  of follicular cells  in the 
plane of rupture. (Bottom) Direct immunofluorescence staining with anti-Fab reveals Ig deposits 
restricted to the inner apical surface.  ×  650. 
structures  without  these  features,  presumably  unbroken  follicles  or  perhaps 
fragments  lying  on  the  split  surface  and  displaying  the  basal  surface  of the 
epithelium.  The  preparations  contained  the  whole  spectrum  of  fragmented 
epithelium,  and  occasional  single  follicular  cells  in  which  the  polarity  of the 
microvilli on the apical pole was still noticeable (Fig. 7 a). 
When the direct IFL test with anti-Fab was applied, only the three thyrotoxic 
glands showed spontaneously bound Ig, the patients all  having significant titers 
of circulating  TMAb.  This  Ig  deposition  on  partially  disrupted  follicles  was 
restricted to the apical border of the epithelium, appearing as a continuous linear 
staining on the inner edge of the row of cells at the ruptured level (Fig. 5 b). At 
the magnification  used (x 650) the fluorescence was apparently  localized at the 
level of cellular microvilli. Complement was not trapped in the Ig deposits. When 
the same follicular preparations  were first incubated with autologous or homol- 
ogous sera  containing  TMAb  before staining  with  anti-Fab,  a  similar  though 
brighter IFL pattern was seen at the apical border (Fig. 6 b). By focusing through 
the three-dimensional  structure of the follicles, a reticulated and dotted pattern 
could be observed on the entire concave surface lining the empty colloid space KHOURY  ET  AL.  585 
FmURE  6.  Partially disrupted follicle from a normal thyroid stained by indirect immunoflu- 
orescence with serum containing thyroid "microsomal" antibodies. At the level of the rupture 
plane photographed under phase-contrast in (a), the surface antigen is seen to be localized to 
the apical pole of the acinar ceils (b). This is confirmed by focusing the microscope on the cells 
at the base of the follicular cavity (c), where confluent fluorescence is clearly apparent (d).  x 
650. 
FIGURE 7.  Isolated follicular cell in suspension immediately after collagenase digestion, seen 
under  phase-contrast  (a).  Stained  by  indirect  immunofluorescence  with  a  TMAb  positive 
serum, shows surface fluorescence localized on the apical pole (b). x  650. 
(Fig. 6 d). Single follicular cells present in the preparations also displayed positive 
cell-surface |FL restricted to the apical pole, simulating a "capping" phenomenon 
(Fig. 7 b). Partially disrupted follicles from all six glands studied by this procedure 
showed the same pattern  of reactivity  with TMAb  positive sera.  Fluorescence 
was  never  seen  on  the  basal  wall  of the  follicular  cells  corresponding  to  the 
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There was no correlation between binding in  vivo of Ig on the surface of 
follicular cells, either in  frozen tissue sections,  monolayer cultures or partially 
disrupted follicles, and the presence of thyrogiobulin antibodies in the patient's 
serum. 
Discussion 
Although circulating antibodies were demonstrated in  autoimmune thyroid 
disease many years ago (13), the exact immunopathologic mechanisms responsible 
for attack on the corresponding target cells in vivo remain unknown. Thyroid 
microsomal and thyroglobulin antibodies are considered useful and convenient 
serum  "markers"  for  the  diagnosis  and  monitoring  of thyroid  autoimmune 
patients. However, we may legitimately ask whether these antibodies represent 
primary or secondary phenomena in the complex events leading to thyroid cell 
damage. The finding that surface-reacting immunoglobulins were present in the 
sera  of autoimmune  thyroid  patients  (14)  and  that  they  were  cytotoxic  for 
dispersed thyroid cells in the presence of complement (9,  15) was undoubtedly 
an important step towards identifying immune phenomena more conspicuously 
related to the initiation of cell injury. Recently, proof was obtained that thyroid 
"microsomal" autoantigens not only have a  cytoplasmic localization within the 
follicular cells, but these molecules are also fully expressed on the cell surface (9, 
16).  A  similar phenomenon has been observed in other organ-specific systems 
(17-19). 
Although it is generally accepted that circulating TMAb tend to be associated 
with clinically overt autoimmune thyroid diseases, their presence in the serum 
does not necessarily imply an active disease and in some cases correlates with a 
silent autoaggressive damaging process that can only be proved on histological 
(20) or biochemical (21) grounds, when deliberately searched for. What is still 
difficult to explain is the paradox than  20%  of "healthy" middle-aged women 
possess TMAb yet only a small proportion of them show thyroid abnormalities 
after many years of follow-up (22,  23).  Furthermore, transplacental passage of 
high titer TMAb from mothers with Hashimoto's thyroiditis or primary myxoe- 
dema does not generally cause neonatal hypothyroidism, unless the rare adenyl 
cyclase-blocking antibody  is  concurrently transferred  to  the  baby  (24).  The 
present demonstration that the autoreactive antigens are exclusively localized on 
the apical microvillous border of thyroid follicular cells facing the colloid space, 
where they would be relatively inaccessible to  circulating antibody,  may now 
explain some of these apparent clinical discrepancies. This topographical restric- 
tion of the target antigen is not altogether unexpected, since the "microsomal" 
antigen in the cytoplasm is believed to be a protein component of the membrane 
of exocytotic vesicles carrying newly synthesized thyroglobulin to be stored in 
the colloid (25,  26).  Fusion of these vesicles with the apical plasma membrane, 
which is known to occur (27,  28),  will  lead to a  consequent expression of the 
antigen on the cell surface at this site. The evenly distributed IFL staining of the 
cell  surface  "microsomai"  antigen  on  human  thyroid  monolayers  may  be  a 
consequence of the preservation of cell polarity on spread-out cultured cells with 
microvilli in  contact with  the culture medium (29).  It is worth  noting,  that a 
preferential concentration of the cytoplasmic "microsomai" antigens at the apical KHOURY  ET  AL.  587 
border of follicular cells was a  common observation on thyroid sections during 
routine determination of thyroid antibodies (Fig.  8) before the introduction of 
the more sensitive hemagglutination test.  This sequestration of antigen on the 
apical cell surface in intact follicles might be the reason for the lack of binding 
of human TMAb to monkey glands in passive transfer experiments, even though 
the  monkey  thyroid  microsomal  antigen  was  fully  cross-reactive  with  human 
TMAb in the indirect IFL test (13). Likewise, this may also explain why thyroiditis 
sera,  cytotoxic  to  follicular  cells  dispersed  in  trypsin  and  to  a  lesser  extent 
collagenase  (9,  25),  failed  to  affect  the  outgrowth  of  undigested  fragments 
presumably because they still maintained their follicular structure in the in vitro 
system (15, 30, 31). 
In the light of these considerations, structural changes of the follicular base- 
ment membrane reported in autoimmune thyroid diseases (32,  33), and related 
to deposition of immune complexes (7), may certainly be of pathogenetic signif- 
icance. While FBM fragmentation seen in thyrotoxic glands is focal and somehow 
restricted  to  those  patients  with  high  thyroid  antibody  titers,  the  changes  in 
Hashimoto's thyroiditis--though qualitatively similar--are diffuse, more severe, 
and always present (32). It is therefore conceivable that tissue damage mediated 
by  the  in  vivo reaction  of cytotoxic  "microsomal" antibodies with cell surface 
determinants on the microvilli might only occur in association with breaks in the 
continuity of the FBM (and perhaps loosening of the tight intercellular junctions), 
with the subsequent leakage of Ig, complement components and/or killer lymph- 
oid cells into the acinar space. Alternative mechanisms of exposing the relevant 
apical autoantigens to the lymphoid system have recently emerged. Reconstituted 
thyroid follicles reverse their polarity in the presence of high concentrations of 
fetal  calf  serum  (34),  so  allowing  the  microvillous  portion  of the  cell  to  be 
externalized (35). HLA-DR antigens are not usually expressed on resting thyroid 
culture cells, but incubation of the same preparations with mitogens stimulates 
these cells to synthesize DR molecules (36). Interestingly, the same phenomenon 
has been observed spontaneously in vivo in autoimmune thyroid glands (37) and 
FIGURE 8.  Indirect  immunofluorescence  on  thyroid  frozen  section  with  TMAb-positive 
serum  giving cytoplasmic staining concentrated  towards  the apical  microvillous pole of the 
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these preliminary results clearly indicate that thyroid epithelial cells have the full 
potential for recognition by autoreactive T  cells, known to have receptors for 
DR antigens (38). 
Our  finding of spontaneously  bound  Ig  on  the  cell-surface of monolayer 
cultures and partially broken follicles derived from the glands of patients with 
autoimmune thyroid disease suggests  that  reaction of TMAb  with  the apical 
surface antigen can indeed occur in vivo. Two facts would indicate that these Ig 
deposits contain TMAb. First, surface-reactive Ig was found only in glands from 
patients with circulating TMAb, irrespective of their clinical diagnosis or func- 
tional status. Secondly, in all the preparations examined, whether monolayers or 
partially broken follicles, the cells invariably displayed an IFL pattern similar to 
that observed when normal viable thyroid cells are stained with TMAb-positive 
sera by the indirect  IFL  technique.  That  this  autoreactivity is  a  true  in  vivo 
phenomenon and not an artifact due to processing in vitro, is suggested by the 
fact that cells cultured from either unwashed or extensively washed neighboring 
portions of the same gland did not differ in their expression of spontaneously 
bound surface Ig and that spontaneous binding did not necessarily parallel the 
presence of TMAb in the circulation, even when present at high titers. Particu- 
larly convincing evidence for the binding of antibody to the apical cell surface in 
vivo is the demonstration of Ig deposition on frozen tissue sections of the glands 
with the same topographical distribution  as that found after staining partially 
broken follicles in suspension. 
The Ig deposits in  vivo were almost exclusively IgG (deposition of IgD and 
IgE was not specifically looked for). Failure of the bound IgG to fix complement 
might  be  a  consequence of low  Ig  binding  density, since  we  know  from the 
brighter IFL staining obtained on subsequent reaction with autologous serum 
that  not  all  antigenic sites  were saturated  in  vivo;  other factors could be  Ig 
subclass restriction (39) or enzymatic damage to the Fc region along the lines 
discussed above.  In any case, one would expect selective loss of cells on which 
the bound Ig had activated the complement cascade. In contrast, the Ig deposits 
on the follicular basal  membrane displayed wider immunological features, in- 
cluding complement fixation. 
In conclusion, several characteristics of the TMAb system would be consistent 
with a pathogenetic role in thyroid autoimmune diseases: the specific autoantigen 
is expressed on the thyroid cell surface; TMAb are almost always present, often 
in high titers, and there is local synthesis by infiltrating lymphoid cells (40); the 
antibodies bind in vivo to the apical surface of follicular cells; and they produce-- 
at least in vitro--an impressive complement-mediated cytotoxic effect on these 
cells. Nevertheless, the presence of TMAb in the circulation and local interstitial 
fluids would be a  necessary but  not sufficient condition for their reactivity in 
vivo,  since access to  the  corresponding cell  surface autoantigen  may require 
additional factors due to its relatively secluded location on the apical pole. 
Summary 
We have shown that thyroid monolayers derived from the glands of patients 
with  autoimmune  thyroid  disease  have  immunoglobulin  (Ig)  bound  to  their 
surface. This appears to have been deposited in vivo rather than during prepa- KHOURY  ET  AL.  589 
ration of the monolayers, a  view supported by our finding of such deposits on 
the apical margin of follicular cells in sections cut from these glands and stained 
with conjugated anti-immunoglobulin.  It is  likely that these deposits represent 
specific binding of so-called  "microsomal" autoantibodies to the surface of the 
thyroid cells in vivo since staining of partially disrupted follicles ("half-melons") 
with  Hashimoto  serum  containing  microsomal  autoantibodies  in  the  indirect 
immunofluorescence (IFL) test, localized the antigen on the apical surface of the 
cells  lining  the  follicular  cavity.  Thus,  paradoxically,  although  the  antigen  is 
relatively inaccessible,  autoantibodies  do  reach  and  combine  with  the  thyroid 
surface in vivo and may therefore play a role in pathogenesis. 
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